CEO Since 2013
The company has return on total asset (ROA) of (21.6) % which means that it has lost $21.6 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (51.33) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 477.23 K in total debt with debt to equity ratio (D/E) of 0.17 which may suggest the company is not taking enough advantage from borrowing. Algae Biosciences Corporation has Current Ratio of 0.03 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Entity SummaryWard Marlatte, Chief Exec. Officer, Sec. and DirectorN/AN/AMr. Marc Joseph Stachiw, Interim Chief Financial Officer and DirectorN/AN/AMr. Anthony H. Smith, 46Exec.N/A0.00 Wayne M. Tinker, Exec.N/A0.00Algae Biosciences Corporation [AGBCF] is traded on OTC Market in USA. It is located in , except where noted. and employs 5 people.
Filter other executives
Algae Biosciences CorporationUSA StockCurrency: USD - US DollarTraded on OTC Market
Fix Your Portfolios with Algae
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Algae Biosciences Corporation to your portfolio
Algae Biosciences Leadership